未登录
分享
收藏
分享
收藏
分享
收藏Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS
Calabresi, PA; Fields, NS; Maloni, HW; Hanham, A; Carlino, J; Moore, J; Levin, MC; Dhib-Jalbut, S; Tranquill, LR; Austin, H; McFarland, HF; Racke, MK
分享
收藏
分享
收藏
分享
收藏Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoireHLA-DR4 (B1 * 0401) 受试者的低亲和力主要组织相容性复合物结合髓磷脂碱性蛋白表位 (残基111-129) 的免疫优势与限制性T细胞受体库有关
Muraro, PA; Vergelli, M; Kalbus, M; Banks, DE; Nagle, JW; Tranquill, LR; Nepom, GT; Biddison, WE; McFarland, HF; Martin, R
分享
收藏